Creating and distributing additional copies is prohibited without the permission of the publisher. Contact subscriptions@latinfinance.com.

BNDESPar Makes Biotech Investment

Jan 22, 2013

BNDESPar has agreed to buy a BRL600m ($294m) stake in of GraalBio, a Brazilian biotechnology...

To continue reading please take a free trial, subscribe or login below.


Already have an account?

Subscribe

Subscribe now for unlimited access to all current and archive news, data and market analysis. 

Subscribe

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

LatinFinance Events

Poll

How busy will LatAm global-local currency debt issuance be this year?

Vote    



  1. Commodities dip raises LatAm growth fears
  2. Institutional wealth – pension funds: The next generation
  3. Man of the year: Seize the moment
  4. LatAm banks return to syndicated loan market
  5. Debt investor scorecard: Beating the benchmark
Follow us


Popular Searches


There is performance risk that the market is going to have to evaluate and assess. I think that is very healthy for the market because that will enable us to finance a much wider range of projects.

Luis Fernando Andrade, Colombian National Infrastructure Agency


Change font size: Switch to default font size Switch to medium font size Switch to large font size

All material is subject to strictly enforced copyright terms & conditions and cannot be repurposed or reproduced. © 2013 Latin American Financial Publications Inc.

Printing isn't available for this page.